The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,401.00
Bid: 2,710.00
Ask: 3,500.00
Change: 0.00 (0.00%)
Spread: 790.00 (29.151%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3,401.00
EXPN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share repurchase programme

6 Oct 2023 15:30

RNS Number : 0232P
Experian plc
06 October 2023
 

Experian plc

 

 

Share repurchase programme

 

 

6 October 2023 - Experian plc (the "Company"), the global information services company, hereby notifies the market that, in continuation of the share repurchase programme announced by the Company on 17 May 2023, it has entered into an irrevocable and non-discretionary arrangement with its broker, J.P. Morgan Securities plc, to purchase on its behalf and within certain pre-set parameters, ordinary shares of 10 US cents each in the Company during the period commencing on 9 October 2023 up to and including 17 November 2023 which period is inclusive of the Company's closed period from 17 October 2023 to 14 November 2023. The Company's half-year financial results are scheduled for release on 15 November 2023.

 

This arrangement is in accordance with Chapter 12 of the UK Listing Authority Listing Rules and the Company's general authority to repurchase shares conferred by the Company's shareholders at the Company's annual general meeting held on 19 July 2023. The purpose of the share repurchase programme is mainly to offset deliveries under employee share plans.

 

 

Contact:

 

Experian

Ronan Hanna

Deputy Company Secretary

+353 (0) 1 846 9128

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 22,000 people operating across 32 countries and every day we're investing in new technologies, talented people, and innovation to help all our clients maximise every opportunity. With corporate headquarters in Dublin, Ireland, we are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUPGQUUUPWGWQ
Date   Source Headline
31st May 20239:32 amRNSAdditional Listing
22nd May 202312:46 pmRNSDirector/PDMR Shareholding
18th May 20232:29 pmRNSDirector/PDMR Shareholding
18th May 202310:20 amRNSDirector/PDMR Shareholding
17th May 20234:00 pmRNSDirector/PDMR Shareholding
17th May 202311:00 amRNSShare repurchases
17th May 20237:00 amRNSFull-year financial report
28th Apr 202310:15 amRNSTotal Voting Rights
12th Apr 20239:30 amRNSAdditional Listing
4th Apr 20239:45 amRNSAdditional Listing
31st Mar 202311:35 amRNSTotal Voting Rights
29th Mar 20239:20 amRNSAdditional Listing
28th Mar 20237:00 amRNSDirectorate Change
22nd Mar 20235:19 pmRNSTransaction in Own Shares
22nd Mar 20239:15 amRNSAdditional Listing
20th Mar 20235:18 pmRNSTransaction in Own Shares
17th Mar 20235:31 pmRNSTransaction in Own Shares
16th Mar 20235:09 pmRNSTransaction in Own Shares
16th Mar 20239:15 amRNSBlock listing Interim Review
15th Mar 20235:14 pmRNSTransaction in Own Shares
15th Mar 20239:15 amRNSAdditional Listing
14th Mar 20235:21 pmRNSTransaction in Own Shares
13th Mar 20235:31 pmRNSTransaction in Own Shares
10th Mar 20236:10 pmRNSTransaction in Own Shares
9th Mar 20235:22 pmRNSTransaction in Own Shares
8th Mar 20235:21 pmRNSTransaction in Own Shares
8th Mar 20239:15 amRNSAdditional Listing
7th Mar 20235:26 pmRNSTransaction in Own Shares
1st Mar 202312:00 pmRNSDirector/PDMR Shareholding
1st Mar 20239:15 amRNSAdditional Listing
28th Feb 202312:20 pmRNSTotal Voting Rights
22nd Feb 202310:00 amRNSAdditional Listing
15th Feb 202310:45 amRNSAdditional Listing
10th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20239:30 amRNSAdditional Listing
1st Feb 20239:15 amRNSAdditional Listing
31st Jan 20232:30 pmRNSDirector Declaration
31st Jan 202310:15 amRNSTotal Voting Rights
25th Jan 20239:15 amRNSAdditional Listing
17th Jan 20237:00 amRNSExperian Q3 FY23 trading update
13th Jan 20235:20 pmRNSFirst interim dividend
9th Jan 20237:00 amRNSDirectorate Change
30th Dec 202210:15 amRNSTotal Voting Rights
16th Dec 202211:30 amRNSElections for first interim dividend
14th Dec 20229:15 amRNSAdditional Listing
7th Dec 20229:00 amRNSAdditional Listing
30th Nov 202211:59 amRNSTotal Voting Rights
16th Nov 20227:00 amRNSHalf-year Report
31st Oct 20229:30 amRNSTotal Voting Rights
14th Oct 20229:51 amRNSShare Repurchase Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.